Lincoln Pharma. Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2023	Jun-2023	Mar-2023	Dec-2022	Sep-2022
Gross Sales	155.99	135.62	112.46	133.77	140.61
Excise Duty	--	--	--	--	--
Net Sales	155.99	135.62	112.46	133.77	140.61
Other Operating Income	--	--	--	--	--
Other Income	8.69	7.69	3.90	6.36	5.72
Total Income	164.68	143.31	116.36	140.12	146.33
Total Expenditure	124.84	114.90	95.82	107.02	111.71
PBIDT	39.84	28.41	20.54	33.11	34.62
Interest	0.39	0.42	1.15	0.33	0.14
PBDT	39.45	27.99	19.39	32.78	34.48
Depreciation	2.58	2.55	2.41	2.26	2.42
Minority Interest Before NP	--	--	--	--	--
Tax	8.61	5.51	3.40	8.47	8.18
Deferred Tax	0.60	0.92	1.01	0.44	0.16
Reported Profit After Tax	27.65	19.01	12.56	21.61	23.71
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	27.65	19.01	12.56	21.61	23.71
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	27.65	19.01	12.56	21.61	23.71
EPS (Unit Curr.)	13.81	9.49	6.27	10.79	11.84
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	20.03	20.03	20.03	20.03	20.03
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	25.54	20.95	18.26	24.75	24.62
PBDTM(%)	25.29	20.64	17.24	24.50	24.52
PATM(%)	17.73	14.02	11.17	16.16	16.86

QuickLinks for Lincoln Pharmaceuticals Ltd.